Taipei, Taiwan

Chu-Chung Lin

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Taichung, TW (2006 - 2009)
  • Taipei, TW (2005 - 2020)

Company Filing History:


Years Active: 2005-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: The Innovations of Chu-Chung Lin

Introduction

Chu-Chung Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating viral infections. With a total of 12 patents to his name, Lin's work has had a substantial impact on medical research and drug development.

Latest Patents

Among his latest patents, Lin has developed cap-dependent endonuclease inhibitors. This invention includes a compound of Formula (I) and its pharmaceutically acceptable salts, metabolites, or prodrugs. The compound is designed to treat influenza effectively. Additionally, he has created trans-isomeric heterocyclic compounds, which are characterized by a trans:cis ratio of at least 70:30. These compounds also come with methods for their preparation, showcasing Lin's innovative approach to pharmaceutical chemistry.

Career Highlights

Lin has worked with notable organizations such as the National Health Research Institutes and Taigen Biotechnology Company, Ltd. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Lin has collaborated with esteemed colleagues, including Ming-Chu Hsu and Chiung-Tong Chen. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Chu-Chung Lin's contributions to pharmaceutical innovation are noteworthy, with a focus on developing effective treatments for viral infections. His extensive patent portfolio and collaborations highlight his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…